tiprankstipranks
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market
AVBP
ArriVent BioPharma, Inc.
RESEARCH TOOLSreports

ArriVent BioPharma, Inc. (AVBP) Income Statement

78 Followers

ArriVent BioPharma, Inc. Income Statement

Last quarter (Q4 2025), ArriVent BioPharma, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, ArriVent BioPharma, Inc.'s net income was $-35.54M. See ArriVent BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 177.53M$ 94.31M$ 74.59M$ 36.91M$ 8.70M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 36.91M$ 0.00
EBITDA
$ -177.53M$ -80.49M$ -74.59M$ 0.00$ -51.61M
Operating Income
$ -177.53M$ -94.31M$ -74.59M$ -36.91M$ -8.70M
Other Income/Expenses
$ 11.23M$ 13.82M$ 5.26M$ 0.00$ -42.91M
Pretax Income
$ -166.31M$ -80.49M$ -69.33M$ -36.91M$ -51.61M
Net Income
$ -166.31M$ -80.49M$ -69.33M$ -36.91M$ -51.61M
Per Share Metrics
Basic EPS
$ -4.32$ -2.56$ -2.17$ -1.10$ -40.44
Diluted EPS
$ -4.32$ -2.56$ -2.17$ -1.10$ -40.44
Weighted Average Shares Outstanding
 38.46M 31.47M 31.96M 33.49M 1.28M
Weighted Average Shares Outstanding (Diluted)
 38.46M 31.47M 31.96M 33.49M 1.28M
Currency in USD

ArriVent BioPharma, Inc. Earnings and Revenue History